ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Alaska » Internal Medicine

Top Internal Medicine Prescribers in Alaska

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID RUDOLPH MD

Internal Medicine

2,772

$229K

97
76 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 30%

$83
Average prescription price

Avg: $76

MARY DEMERS DO

Internal Medicine

2,765

$194K

58
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

24%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 30%

$70
Average prescription price

Avg: $76

PATRICK NOLAN DO

Internal Medicine

2,763

$491K

192
135 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 30%

$178
Average prescription price

Avg: $76

MICHAEL JONES M.D.

Internal Medicine

2,608

$139K

106
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 30%

$53
Average prescription price

Avg: $76

KATHY HURLBURT MD

Internal Medicine

2,501

$283K

110
87 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 30%

$113
Average prescription price

Avg: $76

KRISTIN MITCHELL

Internal Medicine

2,429

$172K

165
126 are 65+

18%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 30%

$71
Average prescription price

Avg: $76

ALEX MALTER M.D.

Internal Medicine

2,409

$170K

111
76 are 65+

19%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 30%

$71
Average prescription price

Avg: $76

ANNE STANDERWICK MD

Internal Medicine

2,342

$205K

86
56 are 65+

17%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 30%

$88
Average prescription price

Avg: $76

NATHANIEL HADDOCK M.D.

Internal Medicine

1,973

$296K

119
93 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 30%

$150
Average prescription price

Avg: $76

TODD GREEN DO

Internal Medicine

1,545

$55.6K

30
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 30%

$36
Average prescription price

Avg: $76

MATTHEW SCHNELLBAECHER MD

Internal Medicine

1,482

$60.7K

126
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 30%

$41
Average prescription price

Avg: $76

CATHERINE KILBY M.D.

Internal Medicine

1,459

$108K

47
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 30%

$74
Average prescription price

Avg: $76

ABDEL BASSET AL-SHAAR MD

Internal Medicine

1,444

$64.4K

177
161 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 30%

$45
Average prescription price

Avg: $76

BRIAN TRIMBLE MD

Internal Medicine

1,226

$52.8K

84
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 30%

$43
Average prescription price

Avg: $76

ANGELICA BALINGIT MD

Internal Medicine

1,172

$93.8K

69
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 30%

$80
Average prescription price

Avg: $76

JED WEIGHT D.O.

Internal Medicine

1,165

$112K

118
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 30%

$96
Average prescription price

Avg: $76

PATRICIA CLANCY M.D.

Internal Medicine

1,121

$35K

113
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 30%

$31
Average prescription price

Avg: $76

JOHN ZIPPERER MD

Internal Medicine

1,096

$52.9K

115
58 are 65+

34%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 30%

$48
Average prescription price

Avg: $76

JOHN MUES M.D.

Internal Medicine

1,044

$96.3K

76
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 30%

$92
Average prescription price

Avg: $76

EILEEN SVERDRUP M.D.

Internal Medicine

942

$79.8K

35
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 30%

$85
Average prescription price

Avg: $76

STEPHEN BURNSIDE MD

Internal Medicine

892

$44.7K

56
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 30%

$50
Average prescription price

Avg: $76

JONATHAN ZARLEY M.D.

Internal Medicine

712

$53.6K

41
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

32%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 30%

$75
Average prescription price

Avg: $76

PETER SAPIN MD

Internal Medicine

493

$18.4K

79
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 30%

$37
Average prescription price

Avg: $76

DAVID TEMPLIN MD

Internal Medicine

436

$72.5K

86
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 30%

$166
Average prescription price

Avg: $76

JAYESH MAKIM MD

Internal Medicine

347

$24.6K

20
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 30%

$71
Average prescription price

Avg: $76

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank